Detalhe da pesquisa
1.
TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.
Proc Natl Acad Sci U S A
; 111(47): 16766-71, 2014 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25385603
2.
Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice.
Br J Haematol
; 191(5): 663-665, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33065776
3.
Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Arch Dermatol Res
; 316(5): 199, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775835
4.
Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
Blood Adv
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607381
5.
Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors.
Front Immunol
; 14: 1291259, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022633
6.
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Cancers (Basel)
; 15(5)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900230
7.
Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients.
Am J Hematol
; 92(2): E15-E17, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27813147
8.
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas.
J Pers Med
; 12(6)2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743749
9.
Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.
J Clin Med
; 11(10)2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628826
10.
CD3e-immunotoxin spares CD62Llo Tregs and reshapes organ-specific T-cell composition by preferentially depleting CD3ehi T cells.
Front Immunol
; 13: 1011190, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36389741
11.
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
Front Oncol
; 12: 858426, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574379
12.
Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage.
Biomedicines
; 10(6)2022 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740248
13.
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis.
Cell Rep
; 41(12): 111826, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543138
14.
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.
Blood Cancer Discov
; 3(2): 154-169, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247900
15.
Novel therapies targeting cutaneous T cell lymphomas and their microenvironment.
Semin Hematol
; 58(2): 103-113, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33906720
16.
Presenting features of indolent primary cutaneous B-cell lymphomas: Distinguishing clinical and histopathologic features.
Clin Dermatol
; 42(1): 93-95, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072295
17.
Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review.
Clin Lymphoma Myeloma Leuk
; 21(2): e120-e125, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060050
18.
Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity.
Cell Stem Cell
; 11(6): 825-35, 2012 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23142520
19.
47-Year-Old Man With Pruritus.
Mayo Clin Proc
; 91(2): 241-5, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26769185
20.
Integrins and proximal signaling mechanisms in cardiovascular disease.
Front Biosci (Landmark Ed)
; 14(6): 2307-34, 2009 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19273203